Big Gain For ImmunoGen, Inc.

Fri 14 Feb 20 at 05:30 PM
Big Gain For ImmunoGen, Inc.

ImmunoGen, Inc. (IMGN:NASDAQ) soared at $6.8, representing a gain of 26.9%. On Thu 13 Feb 20, IMGN:NASDAQ hit a New 2-Week High of $5.36. The stock got featured on our News Catalysts scanner on Fri 14 Feb 20 at 09:23 AM in the 'GROWTH' category. From Fri 24 Jan 20, the stock recorded 64.29% Up Days and 60.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About ImmunoGen, Inc. (IMGN:NASDAQ)

Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.